473 related articles for article (PubMed ID: 28474989)
21. The E3 ligase RNF43 inhibits Wnt signaling downstream of mutated β-catenin by sequestering TCF4 to the nuclear membrane.
Loregger A; Grandl M; Mejías-Luque R; Allgäuer M; Degenhart K; Haselmann V; Oikonomou C; Hatzis P; Janssen KP; Nitsche U; Gradl D; van den Broek O; Destree O; Ulm K; Neumaier M; Kalali B; Jung A; Varela I; Schmid RM; Rad R; Busch DH; Gerhard M
Sci Signal; 2015 Sep; 8(393):ra90. PubMed ID: 26350900
[TBL] [Abstract][Full Text] [Related]
22. Discovery of Selective Small-Molecule Inhibitors for the β-Catenin/T-Cell Factor Protein-Protein Interaction through the Optimization of the Acyl Hydrazone Moiety.
Catrow JL; Zhang Y; Zhang M; Ji H
J Med Chem; 2015 Jun; 58(11):4678-92. PubMed ID: 25985283
[TBL] [Abstract][Full Text] [Related]
23. A Small Molecule Inhibitor of the β-Catenin-TCF4 Interaction Suppresses Colorectal Cancer Growth In Vitro and In Vivo.
Shin SH; Lim DY; Reddy K; Malakhova M; Liu F; Wang T; Song M; Chen H; Bae KB; Ryu J; Liu K; Lee MH; Bode AM; Dong Z
EBioMedicine; 2017 Nov; 25():22-31. PubMed ID: 29033371
[TBL] [Abstract][Full Text] [Related]
24. Activation of Wnt/β-catenin signaling by hydrogen peroxide transcriptionally inhibits NaV1.5 expression.
Wang N; Huo R; Cai B; Lu Y; Ye B; Li X; Li F; Xu H
Free Radic Biol Med; 2016 Jul; 96():34-44. PubMed ID: 27068063
[TBL] [Abstract][Full Text] [Related]
25. Activation of the Wnt/β-catenin pathway represses the transcription of the β-amyloid precursor protein cleaving enzyme (BACE1) via binding of T-cell factor-4 to BACE1 promoter.
Parr C; Mirzaei N; Christian M; Sastre M
FASEB J; 2015 Feb; 29(2):623-35. PubMed ID: 25384422
[TBL] [Abstract][Full Text] [Related]
26. Design, synthesis and evaluation of 4,7-disubstituted 8-methoxyquinazoline derivatives as potential cytotoxic agents targeting β-catenin/TCF4 signaling pathway.
Neogi K; Murumkar PR; Sharma P; Yadav P; Tewari M; Karunagaran D; Nayak PK; Yadav MR
Transl Oncol; 2022 May; 19():101395. PubMed ID: 35325837
[TBL] [Abstract][Full Text] [Related]
27. The Wnt/β-catenin and PI3K/Akt signaling pathways promote EMT in gastric cancer by epigenetic regulation via H3 lysine 27 acetylation.
Song Y; Li ZX; Liu X; Wang R; Li LW; Zhang Q
Tumour Biol; 2017 Jul; 39(7):1010428317712617. PubMed ID: 28671020
[TBL] [Abstract][Full Text] [Related]
28. KSHV vPK inhibits Wnt signaling via preventing interactions between β-catenin and TCF4.
Cha S; Kang MS; Seo T
Biochem Biophys Res Commun; 2018 Feb; 497(1):381-387. PubMed ID: 29432739
[TBL] [Abstract][Full Text] [Related]
29. Dishevelled-DEP domain interacting protein (DDIP) inhibits Wnt signaling by promoting TCF4 degradation and disrupting the TCF4/beta-catenin complex.
Zhang H; Zhang H; Zhang Y; Ng SS; Ren F; Wang Y; Duan Y; Chen L; Zhai Y; Guo Q; Chang Z
Cell Signal; 2010 Nov; 22(11):1753-60. PubMed ID: 20603214
[TBL] [Abstract][Full Text] [Related]
30. Down-regulation of the Wnt/β-catenin signaling pathway by Cacnb4.
Rima M; Daghsni M; Lopez A; Fajloun Z; Lefrancois L; Dunach M; Mori Y; Merle P; Brusés JL; De Waard M; Ronjat M
Mol Biol Cell; 2017 Dec; 28(25):3699-3708. PubMed ID: 29021340
[TBL] [Abstract][Full Text] [Related]
31. The plant sesquiterpene lactone parthenolide inhibits Wnt/β-catenin signaling by blocking synthesis of the transcriptional regulators TCF4/LEF1.
Zhu X; Yuan C; Tian C; Li C; Nie F; Song X; Zeng R; Wu D; Hao X; Li L
J Biol Chem; 2018 Apr; 293(14):5335-5344. PubMed ID: 29462785
[TBL] [Abstract][Full Text] [Related]
32. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
[TBL] [Abstract][Full Text] [Related]
33. Effect of 1,25-dihydroxyvitamin D3 on the Wnt pathway in non-malignant colonic cells.
Gröschel C; Aggarwal A; Tennakoon S; Höbaus J; Prinz-Wohlgenannt M; Marian B; Heffeter P; Berger W; Kállay E
J Steroid Biochem Mol Biol; 2016 Jan; 155(Pt B):224-30. PubMed ID: 25777538
[TBL] [Abstract][Full Text] [Related]
34. A double-negative feedback loop between Wnt-β-catenin signaling and HNF4α regulates epithelial-mesenchymal transition in hepatocellular carcinoma.
Yang M; Li SN; Anjum KM; Gui LX; Zhu SS; Liu J; Chen JK; Liu QF; Ye GD; Wang WJ; Wu JF; Cai WY; Sun GB; Liu YJ; Liu RF; Zhang ZM; Li BA
J Cell Sci; 2013 Dec; 126(Pt 24):5692-703. PubMed ID: 24101726
[TBL] [Abstract][Full Text] [Related]
35. Wnt/β-Catenin Signaling Regulates the Expression of the Ammonium Permease Gene RHBG in Human Cancer Cells.
Merhi A; De Mees C; Abdo R; Victoria Alberola J; Marini AM
PLoS One; 2015; 10(6):e0128683. PubMed ID: 26029888
[TBL] [Abstract][Full Text] [Related]
36. Atypical regulators of Wnt/β-catenin signaling as potential therapeutic targets in Hepatocellular Carcinoma.
Chen J; Rajasekaran M; Hui KM
Exp Biol Med (Maywood); 2017 Jun; 242(11):1142-1149. PubMed ID: 28429652
[TBL] [Abstract][Full Text] [Related]
37. WNT/β-catenin Signaling Pathway and Downstream Modulators in Low- and High-grade Glioma.
Denysenko T; Annovazzi L; Cassoni P; Melcarne A; Mellai M; Schiffer D
Cancer Genomics Proteomics; 2016; 13(1):31-45. PubMed ID: 26708597
[TBL] [Abstract][Full Text] [Related]
38. Discovery of chemical probes that suppress Wnt/β-catenin signaling through high-throughput screening.
Yamaguchi K; Nagatoishi S; Tsumoto K; Furukawa Y
Cancer Sci; 2020 Mar; 111(3):783-794. PubMed ID: 31912579
[TBL] [Abstract][Full Text] [Related]
39. Targeting Wnt-driven cancers: Discovery of novel tankyrase inhibitors.
Ferri M; Liscio P; Carotti A; Asciutti S; Sardella R; Macchiarulo A; Camaioni E
Eur J Med Chem; 2017 Dec; 142():506-522. PubMed ID: 29107427
[TBL] [Abstract][Full Text] [Related]
40. Interferon-α2b and transforming growth factor-β1 treatments on HCC cell lines: Are Wnt/β-catenin pathway and Smads signaling connected in hepatocellular carcinoma?
Ceballos MP; Parody JP; Alvarez Mde L; Ingaramo PI; Carnovale CE; Carrillo MC
Biochem Pharmacol; 2011 Dec; 82(11):1682-91. PubMed ID: 21843516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
